173 related articles for article (PubMed ID: 9612606)
21. A comparison of serial plate agar dilution, Bauer-Kirby disk diffusion, and the Vitek AutoMicrobic system for the determination of susceptibilities of Klebsiella spp., Enterobacter spp., and Pseudomonas aeruginosa to ten antimicrobial agents.
Fekete T; Tumah H; Woodwell J; Truant A; Satishchandran V; Axelrod P; Kreter B
Diagn Microbiol Infect Dis; 1994 Apr; 18(4):251-8. PubMed ID: 7924222
[TBL] [Abstract][Full Text] [Related]
22. Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber model.
Garrison MW; Anderson DE; Campbell DM; Carroll KC; Malone CL; Anderson JD; Hollis RJ; Pfaller MA
Antimicrob Agents Chemother; 1996 Dec; 40(12):2859-64. PubMed ID: 9124855
[TBL] [Abstract][Full Text] [Related]
23. [Comparison between agar dilution and three other methods for determining the susceptibility of 228 clinical isolates of non-fermenting gram-negative rods].
Gómez-Garcés JL; Aracil B; Gil Y
Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):331-7. PubMed ID: 19406523
[TBL] [Abstract][Full Text] [Related]
24. Resistance of Xanthomonas maltophilia to antibiotics and the effect of beta-lactamase inhibitors.
Neu HC; Saha G; Chin NX
Diagn Microbiol Infect Dis; 1989; 12(3):283-5. PubMed ID: 2791491
[TBL] [Abstract][Full Text] [Related]
25. Antibiotic susceptibility profile of Xanthomonas maltophilia. In vitro activity of beta-lactam/beta-lactamase inhibitor combinations.
García-Rodríguez JA; García Sánchez JE; García García MI; García Sánchez E; Muñoz Bellido JL
Diagn Microbiol Infect Dis; 1991; 14(3):239-43. PubMed ID: 1889176
[TBL] [Abstract][Full Text] [Related]
26. Comparative in vitro activity of gatifloxacin against Stenotrophomonas maltophilia and Burkholderia species isolates including evaluation of disk diffusion and E test methods.
Biedenbach DJ; Croco MA; Barrett TJ; Jones RN
Eur J Clin Microbiol Infect Dis; 1999 Jun; 18(6):428-31. PubMed ID: 10442421
[TBL] [Abstract][Full Text] [Related]
27. In vitro activities of antimicrobial combinations against Stenotrophomonas (Xanthomonas) maltophilia.
Poulos CD; Matsumura SO; Willey BM; Low DE; McGeer A
Antimicrob Agents Chemother; 1995 Oct; 39(10):2220-3. PubMed ID: 8619571
[TBL] [Abstract][Full Text] [Related]
28. [Comparative activity of ticarcillin-clavulanic acid and various beta-lactams against Pseudomonas maltophilia].
Monteil H; Jehl F
Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):805-8. PubMed ID: 3309818
[TBL] [Abstract][Full Text] [Related]
29. In vitro activities of antimicrobial combinations against clinical isolates of Stenotrophomonas maltophilia.
Liaw SJ; Teng LJ; Hsueh PR; Ho SW; Luh KT
J Formos Med Assoc; 2002 Jul; 101(7):495-501. PubMed ID: 12353342
[TBL] [Abstract][Full Text] [Related]
30. Antibiotic susceptibility of Serratia marcescens and Serratia liquefaciens.
Traub WH
Chemotherapy; 2000; 46(5):315-21. PubMed ID: 10965096
[TBL] [Abstract][Full Text] [Related]
31. Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients.
Hogardt M; Schmoldt S; Götzfried M; Adler K; Heesemann J
J Antimicrob Chemother; 2004 Dec; 54(6):1057-61. PubMed ID: 15509615
[TBL] [Abstract][Full Text] [Related]
32. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines.
Gales AC; Reis AO; Jones RN
J Clin Microbiol; 2001 Jan; 39(1):183-90. PubMed ID: 11136768
[TBL] [Abstract][Full Text] [Related]
33. Influence of an extended incubation period on values of minimum inhibitory concentrations of antibiotics in Stenotrophomonas maltophilia clinical strains.
Hejnar P; Hamal P; Koukalová D
New Microbiol; 2000 Oct; 23(4):415-21. PubMed ID: 11061630
[TBL] [Abstract][Full Text] [Related]
34. Development of EUCAST disk diffusion method for susceptibility testing of the Bacteroides fragilis group isolates.
Nagy E; Justesen US; Eitel Z; Urbán E;
Anaerobe; 2015 Feb; 31():65-71. PubMed ID: 25464140
[TBL] [Abstract][Full Text] [Related]
35. [Evaluation of the antibiotic sensitivity of Pseudomonas sp. using the API-ATB-PSE system. Comparison with diffusion and the reference agar dilution method].
Delisle F; Lesage D; Gayral JP; Daguet GL; Vergez P; Le Cunff D
Pathol Biol (Paris); 1986 May; 34(5):424-9. PubMed ID: 3534715
[TBL] [Abstract][Full Text] [Related]
36. Agar disk diffusion (Bauer-Kirby) tests with various fastidious and nonfastidious reference (ATCC) strains: comparison of several agar media.
Traub WH; Leonhard B
Chemotherapy; 1994; 40(6):374-83. PubMed ID: 7842820
[TBL] [Abstract][Full Text] [Related]
37. Antimicrobial susceptibility profile of molecular typed cystic fibrosis Stenotrophomonas maltophilia isolates and differences with noncystic fibrosis isolates.
Cantón R; Valdezate S; Vindel A; Sánchez Del Saz B; Maíz L; Baquero F
Pediatr Pulmonol; 2003 Feb; 35(2):99-107. PubMed ID: 12526070
[TBL] [Abstract][Full Text] [Related]
38. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V
J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989
[TBL] [Abstract][Full Text] [Related]
39. [Changes of antimicrobial resistance among nonfermenting gram-negative bacilli isolated from intensive care units from 1994 to 2001 in China].
Wang H; Chen MJ;
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):385-90. PubMed ID: 12820914
[TBL] [Abstract][Full Text] [Related]
40. The antimicrobial susceptibility of Stenotrophomonas maltophilia isolates using three different methods and their genetic relatedness.
Tatman-Otkun M; Gürcan S; Ozer B; Aydoslu B; Bukavaz S
BMC Microbiol; 2005 May; 5():24. PubMed ID: 15882456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]